Methotrexate shows marginal clinical efficiency in early scleroderma

Curr Rheumatol Rep. 2002 Apr;4(2):97-8. doi: 10.1007/s11926-002-0003-3.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Double-Blind Method
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Methotrexate / therapeutic use*
  • Prospective Studies
  • Scleroderma, Systemic / drug therapy*

Substances

  • Immunosuppressive Agents
  • Methotrexate